Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

177

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

January 18, 2029

Study Completion Date

January 18, 2029

Conditions
Metastatic Prostate Cancer
Interventions
DRUG

AZD0516

AZD0516 will be administered via intravenous infusion.

DRUG

AZD9574

AZD9574 will be administered orally.

Trial Locations (51)

5505

NOT_YET_RECRUITING

Research Site, Seoul

10065

NOT_YET_RECRUITING

Research Site, New York

14263

NOT_YET_RECRUITING

Research Site, Buffalo

20089

NOT_YET_RECRUITING

Research Site, Rozzano

20132

NOT_YET_RECRUITING

Research Site, Milan

20133

NOT_YET_RECRUITING

Research Site, Milan

20141

NOT_YET_RECRUITING

Research Site, Milan

28027

NOT_YET_RECRUITING

Research Site, Madrid

29572

RECRUITING

Research Site, Myrtle Beach

31005

NOT_YET_RECRUITING

Research Site, Pamplona

34298

NOT_YET_RECRUITING

Research Site, Montpellier

39008

NOT_YET_RECRUITING

Research Site, Santander

44805

NOT_YET_RECRUITING

Research Site, Saint-Herblain

46009

NOT_YET_RECRUITING

Research Site, Valencia

48109

NOT_YET_RECRUITING

Research Site, Ann Arbor

48201

NOT_YET_RECRUITING

Research Site, Detroit

69008

NOT_YET_RECRUITING

Research Site, Lyon

72703

NOT_YET_RECRUITING

Research Site, Fayetteville

77030

NOT_YET_RECRUITING

Research Site, Houston

80131

NOT_YET_RECRUITING

Research Site, Napoli

90095

NOT_YET_RECRUITING

Research Site, Los Angeles

92151

NOT_YET_RECRUITING

Research Site, Suresnes

94805

NOT_YET_RECRUITING

Research Site, Villejuif

410013

NOT_YET_RECRUITING

Research Site, Changsha

430022

NOT_YET_RECRUITING

Research Site, Wuhan

610041

NOT_YET_RECRUITING

Research Site, Chengdu

02114

NOT_YET_RECRUITING

Research Site, Boston

02906

NOT_YET_RECRUITING

Research Site, Providence

14784-400

NOT_YET_RECRUITING

Research Site, Barretos

90035-001

NOT_YET_RECRUITING

Research Site, Porto Alegre

01401-002

NOT_YET_RECRUITING

Research Site, São Paulo

00168

NOT_YET_RECRUITING

Research Site, Roma

104-0045

NOT_YET_RECRUITING

Research Site, Chūōku

277-8577

NOT_YET_RECRUITING

Research Site, Kashiwa

135-8550

NOT_YET_RECRUITING

Research Site, Kōtoku

75-581

NOT_YET_RECRUITING

Research Site, Koszalin

97-300

NOT_YET_RECRUITING

Research Site, Piotrkow Trybunalski

37-700

NOT_YET_RECRUITING

Research Site, Przemyśl

03080

NOT_YET_RECRUITING

Research Site, Seoul

03722

NOT_YET_RECRUITING

Research Site, Seoul

06351

NOT_YET_RECRUITING

Research Site, Seoul

06591

NOT_YET_RECRUITING

Research Site, Seoul

08035

NOT_YET_RECRUITING

Research Site, Barcelona

08036

NOT_YET_RECRUITING

Research Site, Barcelona

08041

NOT_YET_RECRUITING

Research Site, Barcelona

08908

NOT_YET_RECRUITING

Research Site, L'Hospitalet de Llobregat

CB2 0QQ

NOT_YET_RECRUITING

Research Site, Cambridge

EC1A 7BE

NOT_YET_RECRUITING

Research Site, London

SE1 9RT

NOT_YET_RECRUITING

Research Site, London

PL6 8DH

NOT_YET_RECRUITING

Research Site, Plymouth

SM2 5PT

NOT_YET_RECRUITING

Research Site, Sutton

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Parexel

INDUSTRY

lead

AstraZeneca

INDUSTRY